Skip to main content
AMGN
NASDAQ Life Sciences

Amgen Lifts Full-Year Outlook After Q2 Sales Smash Estimates

Tom Rudovsky · Reported by Binance News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$389.155
Mkt Cap
$210.497B
52W Low
$269.77
52W High
$398
52W Position info
44% above low
Off High info
2.2% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

AMGN sits 44% above its 52-week low of $269.77.

Summary

Amgen raised its full-year profit and revenue guidance after Q2 sales of key medicines beat expectations. The company reported adjusted EPS of $6.29 versus the $5.62 consensus and revenue of $10.1B, driven by stronger-than-expected product sales. This follows a turbulent period marked by the proposed U.S. withdrawal of Tavneos and a recent cybersecurity breach, making the raised outlook a notable positive signal. The guidance hike suggests management sees sustained momentum despite recent headwinds.

At the time of this announcement, AMGN was trading at $389.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $210.5B. The 52-week trading range was $269.77 to $398.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Binance News.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $465.00 info
Change: -$12.40 (-3%) info
Market Cap: $251.886B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $465.00 info
Change: +$0.080 (+0.02%) info
Market Cap: $251.886B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $465.00 info
Change: +$2.00 (+0.43%) info
Market Cap: $251.886B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $465.00 info
Change: +$4.43 (+0.96%) info
Market Cap: $251.886B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $465.00 info
Change: +$16.21 (+4%) info
Market Cap: $251.886B info